Complementary transcriptomic analyses have revealed altered gene expression profiles in HUVECs derived from women with gestational diabetes mellitus (GDM), particularly in pathways associated with metabolism, inflammation, oxidative stress, and insulin signaling [101]. This evidence concerns the gene INS and gestational diabetes.